Chongqing Zhifei Bio Products Market Cap ($4.73 Billion)

$4.73 Billion USD · CN¥32.29 Billion CNY · Rank #3578

Market Cap & Net Worth: Chongqing Zhifei Bio Products (300122)

Chongqing Zhifei Bio Products market cap. Chongqing Zhifei Bio Products (SHE:300122) has a market capitalization of $4.73 Billion (CN¥32.29 Billion) as of November 1, 2026. Listed on the SHE stock exchange, this China-based company holds position #3578 globally and #437 in its home market, demonstrating a 8.53% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chongqing Zhifei Bio Products's stock price CN¥13.49 by its total outstanding shares 2393789747 (2.39 Billion). Also see cash efficiency ratio of Chongqing Zhifei Bio Products for how efficiently the company converts equity into cash flow.

Chongqing Zhifei Bio Products Market Cap History (2015–2026)

Chongqing Zhifei Bio Products market cap history from 2015 to 2026. Data shows growth from $3.85 Billion to $4.73 Billion (4.13% CAGR). Check Chongqing Zhifei Bio Products (300122) stock price for real-time trading data and today's change.

Index Memberships

Chongqing Zhifei Bio Products is a constituent of 1 market index:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
ChiNext CNT	$883.19 Billion	0.54%	#45 of 100

Weight: Chongqing Zhifei Bio Products's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Chongqing Zhifei Bio Products Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Chongqing Zhifei Bio Products's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Chongqing Zhifei Bio Products annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.74x

Chongqing Zhifei Bio Products's market cap is 0.74 times its annual revenue

Industry average: 3868.91x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$3.50 Billion	$445.95 Million	$32.52 Million	7.85x	107.63x
2017	$5.97 Billion	$1.34 Billion	$432.28 Million	4.45x	13.81x
2018	$8.26 Billion	$5.23 Billion	$1.45 Billion	1.58x	5.69x
2019	$10.72 Billion	$10.59 Billion	$2.37 Billion	1.01x	4.53x
2020	$32.02 Billion	$15.19 Billion	$3.30 Billion	2.11x	9.70x
2021	$27.05 Billion	$30.65 Billion	$10.21 Billion	0.88x	2.65x
2022	$19.17 Billion	$38.26 Billion	$7.54 Billion	0.50x	2.54x
2023	$20.77 Billion	$52.92 Billion	$8.07 Billion	0.39x	2.57x
2024	$9.21 Billion	$26.07 Billion	$2.02 Billion	0.35x	4.56x
2025	$6.61 Billion	$8.96 Billion	-$14.72 Billion	0.74x	N/A

Competitor Companies of 300122 by Market Capitalization

Companies near Chongqing Zhifei Bio Products in the global market cap rankings as of November 1, 2026. Also see how large is Chongqing Zhifei Bio Products's balance sheet for a full breakdown of the balance sheet.

Key companies related to Chongqing Zhifei Bio Products by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#182	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.90 Billion	$558.88
#371	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$76.14 Billion	$927.89
#412	CSL Ltd	AU:CSL	$68.91 Billion	AU$200.73
#495	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$221.72

Market Capitalization of Chongqing Zhifei Bio Products (2015–2026)

Market capitalization of Chongqing Zhifei Bio Products from 2015 to today. Between 2015 and today, Chongqing Zhifei Bio Products's market cap moved from $3.85 Billion to $ 4.73 Billion, with a yearly change of 4.13%.

Year	Market Cap	Change (%)
2026	CN¥4.73 Billion	-28.51%
2025	CN¥6.61 Billion	-28.25%
2024	CN¥9.21 Billion	-55.66%
2023	CN¥20.77 Billion	+8.37%
2022	CN¥19.17 Billion	-29.12%
2021	CN¥27.05 Billion	-15.52%
2020	CN¥32.02 Billion	+198.79%
2019	CN¥10.72 Billion	+29.67%
2018	CN¥8.26 Billion	+38.46%
2017	CN¥5.97 Billion	+70.51%
2016	CN¥3.50 Billion	-9.12%
2015	CN¥3.85 Billion	--

End of Day Market Cap According to Different Sources

On Oct 31st, 2026 the market cap of Chongqing Zhifei Bio Products was reported to be:

Source	Market Cap
Yahoo Finance	$4.73 Billion USD
MoneyControl	$4.73 Billion USD
MarketWatch	$4.73 Billion USD
marketcap.company	$4.73 Billion USD
Reuters	$4.73 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Chongqing Zhifei Bio Products

SHE:300122 China Biotechnology

Market Cap

$4.73 Billion

CN¥32.29 Billion CNY

Market Cap Rank

#3578 Global

#437 in China

Share Price

CN¥13.49

Change (1 day)

+4.74%

52-Week Range

CN¥11.37 - CN¥21.77

All Time High

CN¥11976.62